|Articles|August 1, 2017
- Pharmaceutical Executive-08-01-2017
- Volume 37
- Issue 8
Pharmaceutical Executive, August 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Health Policy Problem Solver: Fumie Griegoalmost 9 years ago
Dealmaking in 2017: Striking a Balancealmost 9 years ago
Beyond the Science: Commercial Implications From ASCO 2017almost 9 years ago
News Spotlight: Pharmaalmost 9 years ago
Pharma’s Marijuana Makeoveralmost 9 years ago
The 'Hear' and Now for Pharma and Social Mediaalmost 9 years ago
Pressure Mounts on FDA, Pharma to Tackle Opioid Abusealmost 9 years ago
Syncing Social Media With Value-Care Modelalmost 9 years ago
AI-based Social Listening as Aid to Pharmacovigilancealmost 9 years ago
Country Report: IndonesiaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
4
Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration
5